Where does Komathi Stem work?

Komathi Stem is Board of Directors at CoPeace Capital and Executive at Glooko.

Where did Komathi Stem go to school?

Komathi Stem studied at University of Virginia (Master's degree, Biomedical/Medical Engineering); University of Virginia (MA, Biomedical Engineering); St. Olaf College (Bachelor of Science (BS), Mathematics).

Komathi Stem

Investor

Board of Directors at CoPeace Capital · Executive at Glooko

Palo Alto, California, United States

Find your path to Komathi

405 people in our graph share verified history with Komathi — schools, employers, funds. One of them is your warm intro.

James WangunlockedKomathi: together at Oncoustic (2022–2026)

×6Komathi: together at Genentech

Komathi: together at University of Virginia

×4Komathi: together at AstraZeneca

About

Komathi Stem is a pharmaceutical and health IT executive with over 30 years of experience in drug development and healthcare technology. She has held leadership positions at companies including Eli Lilly, AstraZeneca, and Genentech, managing R&D and commercial functions with P&L responsibilities exceeding $50M across oncology, endocrine, cardio-metabolic, and other therapeutic domains. Stem co-founded Science 37 and monARC Bionetworks, which together raised over $150M in funding, and currently serves as Strategic Advisor at Oncoustics.

Executive at Glooko

Intro paths

→

In turn, Komathi can intro founders to Glooko's investors below.

Glooko's investors · 3

Canaan PartnersStamford · $500K – $20M checks · since 2021 Health Catalyst CapitalNew York Samsung NextSan Jose · $100K – $5M checks

Experience

OncousticsStrategic Advisorcurrent2021 — presentSan Francisco Bay Area
ReThynk ConsultingChief Executive Officercurrent2016 — presentPalo Alto, California, United States
CoPeaceBoard Membercurrent2018 — presentDenver, Colorado, United States
GlookoChief Operating Officer2020 — 2024Palo Alto, CA
monARC Bionetworks, Inc.Founder and CEO2016 — 2019Palo Alto, CA
GenentechStrategic Innovation Consultant2016 — 2017
GenentechSr. Director, Product Development2006 — 2016South San Francisco
Science 37, Inc.Chief Operating Officer and Strategic Advisor2014 — 2016Los Angeles Metropolitan Area
AstraZenecaSr. Director2003 — 2006
Eli Lilly and CompanyVariety of Positions1992 — 2003Indianapolis

Skills & more

Patient RecruitmentHuman Resources (HR)Strategic LeadershipResearch and Development (R&D)Strategic PartnershipsLeadershipBoard of DirectorsPatient AdvocacyBiopharmaceuticalsBusiness StrategyKey MetricsFinancial Modeling

+12 more

FinancePatient EngagementDigital StrategyAI/ML SolutionsCorporate StrategyCreativity and InnovationDecentralized clinical trialsRemote Patient MonitoringCTMSClinical Trial Management System (CTMS)Product DevelopmentRegulatory Affairs

Languages Tamil

From Komathi's professional profile.

Colleagues at CoPeace Capital

Andy Eckert

COO at CoPeace Capital

Barbara Winter

Impact Director at CoPeace Capital

Betsy Poell

Advisory Council at CoPeace Capital

Brad Tompkins

Board of Directors at CoPeace Capital

Craig Jonas

Managing Partner at SVX

Craig Jonas

CEO and Founder at CoPeace Capital

Craig Jonas, Ph.D.

Founder & CEO at CoPeace Capital

Dan Hattori

Strategic Financial Advisor at CoPeace Capital

Frequently asked questions

Who is Komathi Stem?: Komathi Stem is a pharmaceutical and health IT executive with over 30 years of experience in drug development and healthcare technology. She has held leadership positions at companies including Eli Lilly, AstraZeneca, and Genentech, managing R&D and commercial functions with P&L responsibilities exceeding $50M across oncology, endocrine, cardio-metabolic, and other therapeutic domains. Stem co-founded Science 37 and monARC Bionetworks, which together raised over $150M in funding, and currently serves as Strategic Advisor at Oncoustics.
Where does Komathi Stem work?: Komathi Stem is Board of Directors at CoPeace Capital and Executive at Glooko.
Where did Komathi Stem go to school?: Komathi Stem studied at University of Virginia (Master's degree, Biomedical/Medical Engineering); University of Virginia (MA, Biomedical Engineering); St. Olaf College (Bachelor of Science (BS), Mathematics).

Same school

Also attended University of Virginia806

Alexis OhanianFounder & General Partner of Seven Seven Six Andy FligelSenior Managing Director at Intel Capital Kandace ElamVice President of GTM Talent at Menlo Ventures Trevor KienzleInvestor at Correlation Ventures Lauren von ReynInvestor at Lightbank Frank RotmanCo-Founder and Partner Emeritus at QED Investors

+ 800 more

Also attended St. Olaf College29

Galen MasonManaging Director at Service Provider Capital Marina DuAssociate at Hitachi Ventures Jeff CaputoExecutives in Residence at GENERAL INCEPTION Margo HaysSenior Advisor at TSG Consumer Partners Tyler HayesPrincipal at Thuja Capital Greg Van GuilderCIO at ECMC Group

+ 23 more

Shared employers

Also worked at Oncoustics3

James WangGeneral Partner at Creative Ventures Emmanuel HuiInvestor at Saltagen Ventures Andrew ValenciaLeadership Team at Qpoint

Also worked at Glooko9

Pablo BariolaInvestor at Inception Studio Capital Russ JohannessonChief Executive Officer, Caregentic at Aegis Ventures Jason DonahueManaging Member at Realization Capital Partners Will VaughnOperating Advisor, UX at Workshop Venture Partners Clay DavidsonExecutive Officer at Glooko Prakash MenonExecutive Officer at Glooko

+ 3 more

Also worked at Genentech247

David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at Medicxi Logan HilleLife Sciences Analyst at CincyTech Josephine ChenInvestor at Sequoia Capital Abbie CelnikerInvestor at Third Rock Ventures

+ 241 more

Also worked at Science 37, Inc.7

Cris De LucaPartner, Digital at Sanofi Ventures Anita ModiCo-Founder & CEO at Peer AI Noah CraftFounder at People Science Michael ShiptonChief Business Officer at Lightship Darcy FormanChief Operating Officer at Lightship Jay TrepanierChief Financial Officer at Paradigm Health

+ 1 more